Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study
Authors
Keywords
-
Journal
International Journal of Clinical Oncology
Volume 27, Issue 1, Pages 194-201
Publisher
Springer Science and Business Media LLC
Online
2021-10-04
DOI
10.1007/s10147-021-02041-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study
- (2021) Yoichiro Tohi et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Association of Age With Risk of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Active Surveillance
- (2021) Claire M. de la Calle et al. UROLOGY
- Active surveillance for intermediate risk prostate cancer: A systematic review and meta-analysis of current protocols and outcomes.
- (2020) Dmitry Enikeev et al. Clinical Genitourinary Cancer
- The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study
- (2020) Yoichiro Tohi et al. International Journal of Clinical Oncology
- Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer
- (2020) Lars Björnebo et al. WORLD JOURNAL OF UROLOGY
- Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance
- (2018) Rebecka Arnsrud Godtman et al. JOURNAL OF UROLOGY
- Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options
- (2018) Martin G. Sanda et al. JOURNAL OF UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance
- (2017) Yaw A. Nyame et al. JOURNAL OF UROLOGY
- Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery
- (2016) Jeffrey J. Tosoian et al. EUROPEAN UROLOGY
- Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial
- (2016) Rebecka Arnsrud Godtman et al. EUROPEAN UROLOGY
- A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment
- (2016) Leonard P. Bokhorst et al. EUROPEAN UROLOGY
- Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience
- (2016) Hima Bindu Musunuru et al. JOURNAL OF UROLOGY
- Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer
- (2015) Jeffrey J. Tosoian et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
- (2015) Laurence Klotz et al. JOURNAL OF CLINICAL ONCOLOGY
- Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPAN
- (2014) Mikio Sugimoto et al. WORLD JOURNAL OF UROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started